Literature DB >> 12512959

Effects of muscarinic toxins MT1 and MT2 from green mamba on different muscarinic cholinoceptors.

Alan L Harvey1, Edgar Kornisiuk, Karen N Bradley, Carlos Cerveñansky, Rosario Durán, Martin Adrover, Gonzalo Sánchez, Diana Jerusalinsky.   

Abstract

MT1 and MT2, polypeptides from green mamba venom, known to bind to muscarinic cholinoceptors, behave like muscarinic agonists in an inhibitory avoidance task in rats. We have further characterised their functional effects using different preparations. MT1 and MT2 behaved like relatively selective muscarinic M1 receptor agonists in rabbit vas deferens, but their effects were not reversed by washing or prevented by muscarinic antagonists, although allosteric modulators altered responses to MT1. Radioligand binding experiments indicated that both toxins irreversibly inhibited [3H]N-methylscopolamine binding to cloned muscarinic M1 and M4 receptors, and reduced binding to M5 subtype with lower affinity, while they reversibly inhibited the binding of [3H]prazosin to rat cerebral cortex and vas deferens, with 20 fold lower affinity. High concentrations of MT1 reversibly blocked responses of vas deferens to noradrenaline. MT1 and MT2 appear to irreversibly activate muscarinic M1 receptors at a site distinct from the classical one, and to have affinity for some alpha-adrenoceptors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12512959     DOI: 10.1023/a:1021660708187

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  37 in total

1.  Amino acid sequence of a snake venom toxin that binds to the muscarinic acetylcholine receptor.

Authors:  E Karlsson; C Risinger; M Jolkkonen; C Wernstedt; A Adem
Journal:  Toxicon       Date:  1991       Impact factor: 3.033

2.  On the unique binding and activating properties of xanomeline at the M1 muscarinic acetylcholine receptor.

Authors:  A Christopoulos; T L Pierce; J L Sorman; E E El-Fakahany
Journal:  Mol Pharmacol       Date:  1998-06       Impact factor: 4.436

Review 3.  Muscarinic receptor subtype selective toxins.

Authors:  A Adem; E Karlsson
Journal:  Life Sci       Date:  1997       Impact factor: 5.037

4.  Analysis of the muscarinic receptor subtype mediating inhibition of the neurogenic contractions in rabbit isolated vas deferens by a series of polymethylene tetra-amines.

Authors:  R Budriesi; S Cacciaguerra; R D Toro; M L Bolognesi; A Chiarini; A Minarini; M Rosini; S Spampinato; V Tumiatti; C Melchiorre
Journal:  Br J Pharmacol       Date:  2001-03       Impact factor: 8.739

5.  Tetrahydroaminoacridine and other allosteric antagonists of hippocampal M1 muscarine receptors.

Authors:  L T Potter; C A Ferrendelli; H E Hanchett; M A Hollifield; M V Lorenzi
Journal:  Mol Pharmacol       Date:  1989-05       Impact factor: 4.436

6.  A toxin from the green mamba Dendroaspis angusticeps: amino acid sequence and selectivity for muscarinic m4 receptors.

Authors:  M Jolkkonen; P L van Giersbergen; U Hellman; C Wernstedt; E Karlsson
Journal:  FEBS Lett       Date:  1994-09-19       Impact factor: 4.124

7.  Studies on RX 781094: a selective, potent and specific antagonist of alpha 2-adrenoceptors.

Authors:  J C Doxey; A G Roach; C F Smith
Journal:  Br J Pharmacol       Date:  1983-03       Impact factor: 8.739

8.  Purification and properties of m1-toxin, a specific antagonist of m1 muscarinic receptors.

Authors:  S I Max; J S Liang; L T Potter
Journal:  J Neurosci       Date:  1993-10       Impact factor: 6.167

9.  Characterization of the prejunctional muscarinic receptors mediating inhibition of evoked release of endogenous noradrenaline in rabbit isolated vas deferens.

Authors:  U Grimm; H Fuder; U Moser; H G Bümert; E Mutschler; G Lambrecht
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-01       Impact factor: 3.000

10.  Antagonist binding profiles of five cloned human muscarinic receptor subtypes.

Authors:  F Dörje; J Wess; G Lambrecht; R Tacke; E Mutschler; M R Brann
Journal:  J Pharmacol Exp Ther       Date:  1991-02       Impact factor: 4.030

View more
  14 in total

Review 1.  Venom effects on monoaminergic systems.

Authors:  Aviva Weisel-Eichler; Frederic Libersat
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2004-05-25       Impact factor: 1.836

2.  Green mamba peptide targets type-2 vasopressin receptor against polycystic kidney disease.

Authors:  Justyna Ciolek; Helen Reinfrank; Loïc Quinton; Say Viengchareun; Enrico A Stura; Laura Vera; Sabrina Sigismeau; Bernard Mouillac; Hélène Orcel; Steve Peigneur; Jan Tytgat; Laura Droctové; Fabrice Beau; Jerome Nevoux; Marc Lombès; Gilles Mourier; Edwin De Pauw; Denis Servent; Christiane Mendre; Ralph Witzgall; Nicolas Gilles
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-19       Impact factor: 11.205

3.  Adrenoceptor activity of muscarinic toxins identified from mamba venoms.

Authors:  K Näreoja; J P Kukkonen; S Rondinelli; D M Toivola; J Meriluoto; J Näsman
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

Review 4.  The Molecular Basis of Toxins' Interactions with Intracellular Signaling via Discrete Portals.

Authors:  Adi Lahiani; Ephraim Yavin; Philip Lazarovici
Journal:  Toxins (Basel)       Date:  2017-03-16       Impact factor: 4.546

5.  Identification of a novel snake peptide toxin displaying high affinity and antagonist behaviour for the α2-adrenoceptors.

Authors:  Céline Rouget; Loïc Quinton; Arhamatoulaye Maïga; Céline Gales; Geoffrey Masuyer; Christian Malosse; Julia Chamot-Rooke; Robert Thai; Gilles Mourier; Edwin De Pauw; Nicolas Gilles; Denis Servent
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

6.  Isolation and pharmacological characterization of AdTx1, a natural peptide displaying specific insurmountable antagonism of the alpha1A-adrenoceptor.

Authors:  L Quinton; E Girard; A Maiga; M Rekik; P Lluel; G Masuyer; M Larregola; C Marquer; J Ciolek; T Magnin; R Wagner; J Molgó; R Thai; C Fruchart-Gaillard; G Mourier; J Chamot-Rooke; A Ménez; S Palea; D Servent; N Gilles
Journal:  Br J Pharmacol       Date:  2009-12-15       Impact factor: 8.739

7.  Transcriptomic analysis of the venom gland of the red-headed krait (Bungarus flaviceps) using expressed sequence tags.

Authors:  Ang Swee Siang; Robin Doley; Freek J Vonk; R Manjunatha Kini
Journal:  BMC Mol Biol       Date:  2010-03-29       Impact factor: 2.946

8.  Structural and functional characterization of a novel homodimeric three-finger neurotoxin from the venom of Ophiophagus hannah (king cobra).

Authors:  Amrita Roy; Xingding Zhou; Ming Zhi Chong; Dieter D'hoedt; Chun Shin Foo; Nandhakishore Rajagopalan; Selvanayagam Nirthanan; Daniel Bertrand; J Sivaraman; R Manjunatha Kini
Journal:  J Biol Chem       Date:  2010-01-13       Impact factor: 5.157

9.  Muscarinic inhibition of hippocampal and striatal adenylyl cyclase is mainly due to the M(4) receptor.

Authors:  Gonzalo Sánchez; Natalia Colettis; Pablo Vázquez; Carlos Cerveñansky; Alejandra Aguirre; Jorge A Quillfeldt; Diana Jerusalinsky; Edgar Kornisiuk
Journal:  Neurochem Res       Date:  2009-02-04       Impact factor: 3.996

10.  Engineering of three-finger fold toxins creates ligands with original pharmacological profiles for muscarinic and adrenergic receptors.

Authors:  Carole Fruchart-Gaillard; Gilles Mourier; Guillaume Blanchet; Laura Vera; Nicolas Gilles; Renée Ménez; Elodie Marcon; Enrico A Stura; Denis Servent
Journal:  PLoS One       Date:  2012-06-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.